Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis
Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan
Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan
View: Text | PDF
Research Article

Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis

  • Text
  • PDF
Abstract

Rheumatoid arthritis (RA) is characterized by synovial joint inflammation, cartilage damage, and dysregulation of the adaptive immune system. While neutrophil extracellular traps (NETs) have been proposed to play a role in the generation of modified autoantigens and in the activation of synovial fibroblasts, it remains unknown whether NETs are directly involved in cartilage damage. Here, we report a new mechanism by which NET-derived elastase disrupts cartilage matrix and induces release of membrane-bound peptidylarginine deiminase-2 by fibroblast-like synoviocytes (FLSs). Cartilage fragments are subsequently citrullinated, internalized by FLSs, and then presented to antigen-specific CD4+ T cells. Furthermore, immune complexes containing citrullinated cartilage components can activate macrophages to release proinflammatory cytokines. HLA-DRB1*04:01 transgenic mice immunized with NETs develop autoantibodies against citrullinated cartilage proteins and display enhanced cartilage damage. Inhibition of NET-derived elastase rescues NET-mediated cartilage damage. These results show that NETs and neutrophil elastase externalized in these structures play fundamental pathogenic roles in promoting cartilage damage and synovial inflammation. Strategies targeting neutrophil elastase and NETs could have a therapeutic role in RA and in other inflammatory diseases associated with inflammatory joint damage.

Authors

Carmelo Carmona-Rivera, Philip M. Carlucci, Rishi R. Goel, Eddie James, Stephen R. Brooks, Cliff Rims, Victoria Hoffmann, David A. Fox, Jane H. Buckner, Mariana J. Kaplan

×

Figure 4

NET-bound neutrophil elastase promotes the release of PAD2 by FLSs and citrullination of extracellular matrix proteins.

Options: View larger image (or click on image) Download as PowerPoint
NET-bound neutrophil elastase promotes the release of PAD2 by FLSs and c...
(A) Western blot analysis quantifying PAD2 and PAD4 expression in OA and RA FLSs. HeLa cells and neutrophil extracts were used as positive controls for PAD2 and PAD4, respectively. Tubulin was used as a loading control. (B) PAD2 expression in RA FLSs by flow cytometry analysis. (C) Representative immunofluorescence of PAD2 expression in the membrane of RA FLSs. (D) Detection of PAD2 in the supernatants of RA FLSs incubated with NETs in the presence or absence of neutrophil elastase inhibitor. PAD2 activity was measured by detecting citrullinated (E) aggrecan, (F) biglycan, and (G) clusterin using Rh-PG citrulline probe in RA supernatants in the presence or absence of NETs. Recombinant PAD2 was used as a control. Results are representative of 3 independent experiments. Scale bar: 10 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts